| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268343 | Journal of Clinical Virology | 2005 | 6 Pages |
Abstract
Our findings suggest that the safety of 600Â mg of ZDV is similar to 400Â mg/day of ZDV and the existence of mechanisms that compensate for anemia and for the neutropenia associated with long-term use of Combivir.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Shuzo Matsushita, Kazuhisa Yoshimura, Tetsuya Kimura, Asako Kamihira, Misao Takano, Kenichiro Eto, Takuma Shirasaka, Hiroaki Mitsuya, Shinichi Oka,